Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G H Miller

Showing results (61-70 of 142) with videos related to

Pageof 15
Sort By:
Journal of Clinical Psychology|October 1, 1979
The relationship between various dietary factors and MMPI subscales: implications for clinical practiceJ C Weinberg, H P Mandel, G H Miller
The New England Journal of Medicine|June 14, 1979
Bronchial epithelium and cigarette smokingG H Miller, W Harada, L Pearson, et al.
Chemotherapy|January 1, 1972
Kinetics and mechanisms of action of trimethoprim and sulfonamides, alone or in combination, upon Escherichia coliJ K Seydel, E Wempe, G H Miller, et al.
The Journal of Infectious Diseases|November 1, 1973
Quantification of the antibacterial action of trimethoprim alone and in combination with sulfonamides by bacterial growth kineticsJ K Seydel, E Wempe, G H Miller, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 1, 1996
Aminoglycoside resistance among Danish blood culture isolates of coagulase-negative staphylococciC Busch-Sørensen, N Frimodt-Møller, G H Miller, et al.
Journal of Medicinal Chemistry|January 1, 1974
Sulfonamide structure-activity relationships in a cell-free system. 2. Proof for the formation of a sulfonamide-containing folate analogL Bock, G H Miller, K J Schaper, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1976
Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibioticG H Miller, G Arcieri, M J Weinstein, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1990
Resistance to aminoglycoside antibiotics in gram-negative bacilli and staphylococci isolated from blood. Report from a European collaborative study. The ESGAR Study Group (European Study Group on Antibiotic Resistance)K Dornbusch, G H Miller, R S Hare, et al.
Journal of Pharmaceutical Sciences|January 1, 1977
Antibacterial structure-activity relationships obtained with resistant microorganisms I: Inhibition of R-factor resistant Escherichia coli by tetracyclinesG H Miller, H L Smith, W L Rock, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1978
Chemotherapeutic evaluation of 5-episisomicin (Sch 22591), a new semisynthetic aminoglycosideJ A Waitz, G H Miller, E Moss, et al.
Pageof 15

Showing results (61-70 of 142) with videos related to

Sort By:
Pageof 15
Journal of Clinical Psychology|October 1, 1979
The relationship between various dietary factors and MMPI subscales: implications for clinical practiceJ C Weinberg, H P Mandel, G H Miller
The New England Journal of Medicine|June 14, 1979
Bronchial epithelium and cigarette smokingG H Miller, W Harada, L Pearson, et al.
Chemotherapy|January 1, 1972
Kinetics and mechanisms of action of trimethoprim and sulfonamides, alone or in combination, upon Escherichia coliJ K Seydel, E Wempe, G H Miller, et al.
The Journal of Infectious Diseases|November 1, 1973
Quantification of the antibacterial action of trimethoprim alone and in combination with sulfonamides by bacterial growth kineticsJ K Seydel, E Wempe, G H Miller, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 1, 1996
Aminoglycoside resistance among Danish blood culture isolates of coagulase-negative staphylococciC Busch-Sørensen, N Frimodt-Møller, G H Miller, et al.
Journal of Medicinal Chemistry|January 1, 1974
Sulfonamide structure-activity relationships in a cell-free system. 2. Proof for the formation of a sulfonamide-containing folate analogL Bock, G H Miller, K J Schaper, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1976
Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibioticG H Miller, G Arcieri, M J Weinstein, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1990
Resistance to aminoglycoside antibiotics in gram-negative bacilli and staphylococci isolated from blood. Report from a European collaborative study. The ESGAR Study Group (European Study Group on Antibiotic Resistance)K Dornbusch, G H Miller, R S Hare, et al.
Journal of Pharmaceutical Sciences|January 1, 1977
Antibacterial structure-activity relationships obtained with resistant microorganisms I: Inhibition of R-factor resistant Escherichia coli by tetracyclinesG H Miller, H L Smith, W L Rock, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1978
Chemotherapeutic evaluation of 5-episisomicin (Sch 22591), a new semisynthetic aminoglycosideJ A Waitz, G H Miller, E Moss, et al.
Pageof 15